LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis

por Zhang, Yan, Hu, Chun-Fang, Chen, Jing, Yan, Li-Xu, Zeng, Yi-Xin, Shao, Jian-Yong
Publicado 2010

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

por Zhang, Ming, Pang, Hua-Jin, Zhao, Wei, Li, Yu-Fa, Yan, Li-Xu, Dong, Zhong-Yi, He, Xiao-Feng
Publicado 2018

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A

por Du, Zi-Ming, Hu, Li-Fu, Wang, Hai-Yun, Yan, Li-Xu, Zeng, Yi-Xin, Shao, Jian-Yong, Ernberg, Ingemar
Publicado 2011

Benign disease prone to be misdiagnosed as malignant pulmonary nodules: Minute meningothelioid nodules

por Peng, Xiao‐Xiao, Yan, Li‐Xu, Liu, Chao, Wang, Si‐Yun, Li, Wen‐Feng, Gao, Xing, Wei, Xue‐Wu, Zhou, Qing
Publicado 2019

Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma

por Chen, Jing, Hu, Chun-Fang, Hou, Jing-Hui, Shao, Qiong, Yan, Li-Xu, Zhu, Xiao-Feng, Zeng, Yi-Xin, Shao, Jian-Yong
Publicado 2010

MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

por Yan, Li-Xu, Liu, Yan-Hui, Luo, Dong-Lan, Zhang, Fen, Cheng, Yu, Luo, Xin-Lan, Xu, Jie, Cheng, Jie, Zhuang, Heng-Guo
Publicado 2014

Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

por Yan, Li-Xu, Liu, Yan-Hui, Luo, Dong-Lan, Zhang, Fen, Cheng, Yu, Luo, Xin-Lan, Xu, Jie, Cheng, Jie, Zhuang, Heng-Guo
Publicado 2018

Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

por Zhang, Chao, Yin, Kai, Liu, Si-Yang, Yan, Li-Xu, Su, Jian, Wu, Yi-Long, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Xue-Ning
Publicado 2021

Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels

por Lin, Zi-Ying, Liang, Zhen-Xing, Zhuang, Pei-Lin, Chen, Jie-Wei, Cao, Yun, Yan, Li-Xu, Yun, Jing-Ping, Xie, Dan, Cai, Mu-Yan
Publicado 2016

Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1

por Wu, Wen-rui, Sun, Hong, Zhang, Rui, Yu, Xian-huan, Shi, Xiang-de, Zhu, Man-sheng, Zeng, Hong, Yan, Li-xu, Xu, Lei-bo, Liu, Chao
Publicado 2016

Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma

por Cai, Mu-Yan, Wang, Feng-Wei, Li, Chang-Peng, Yan, Li-Xu, Chen, Jie-Wei, Luo, Rong-Zhen, Yun, Jing-Ping, Zeng, Yi-Xin, Xie, Dan
Publicado 2016

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors

por Jiang, Ben‐Yuan, Zhang, Jia‐Tao, Yan, Li‐Xu, Chu, Xiang‐Peng, Nie, Qiang, Cui, Jian‐Xiu, Yang, Xue‐Ning, Zhong, Wen‐Zhao, Wu, Yi‐Long
Publicado 2021

Prognostic value of delta-like protein 3 combined with thyroid transcription factor-1 in small-cell lung cancer

por Yan, Li-Xu, Liu, Yan-Hui, Li, Zhi, Luo, Dong-Lan, Li, Yu-Fa, Yan, Jing-Hai, Zhang, Jia-Tao, Liu, Chao, Liu, Xun-Hua, He, Jiao
Publicado 2019

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness

por Xu, Fang‐Ping, Liu, Yan‐Hui, Luo, Xin‐Lan, Zhang, Fen, Zhou, Hai‐Yu, Ge, Yan, Liu, Chao, Chen, Jie, Luo, Dong‐Lan, Yan, Li‐Xu, Mei, Ping, Xu, Jie, Zhuang, Heng‐Guo
Publicado 2016

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth

por Yan, Li Xu, Wu, Qi Nian, Zhang, Yan, Li, Yang Yang, Liao, Ding Zhun, Hou, Jing Hui, Fu, Jia, Zeng, Mu Sheng, Yun, Jing Ping, Wu, Qiu Liang, Zeng, Yi Xin, Shao, Jian Yong
Publicado 2011

Dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer

por Chen, Zhi‐Yong, Fu, Rui, Tan, Xiao‐Yue, Yan, Li‐Xu, Tang, Wen‐Fang, Qiu, Zhen‐Bin, Qi, Yi‐Fan, Li, Yu‐Fa, Hou, Qing‐Yi, Wu, Yi‐Long, Zhong, Wen‐Zhao, Jiang, Ben‐Yuan
Publicado 2022

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

por Zhang, Fen, Yan, Li-Xu, Lin, Su-Xia, Ye, Zi-Yin, Zhuang, Heng-Guo, Yun, Jing-Ping, Lin, Han-Liang, Luo, Dong-Lan, Xu, Fang-Ping, Luo, Xin-Lan, Cheng, Jie, Zhang, Ke-Ping, Liu, Yan-Hui
Publicado 2013

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

por YAN, LI-XU, LIU, YAN-HUI, XIANG, JIAN-WEN, WU, QI-NIAN, XU, LEI-BO, LUO, XIN-LAN, ZHU, XIAO-LAN, LIU, CHAO, XU, FANG-PING, LUO, DONG-LAN, MEI, PING, XU, JIE, ZHANG, KE-PING, CHEN, JIE
Publicado 2015

Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma

por Zhang, Jia-Tao, Zhang, Juan, Wang, Song-Rong, Yan, Li-Xu, Qin, Jing, Yin, Kai, Chu, Xiang-Peng, Wang, Meng-Min, Hong, Hui-Zhao, Lv, Zhi-Yi, Dong, Song, Jiang, Ben-Yuan, Zhang, Xu-Chao, Liu, Xiang, Zhou, Qing, Wu, Yi-Long, Zhong, Wen-Zhao
Publicado 2023

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

por Zhang, Chao, Chen, Hua-Fei, Yan, Shi, Wu, Lin, Yan, Li-Xu, Yan, Xiao-Long, Yue, Dong-Sheng, Xu, Chun-Wei, Zheng, Min, Li, Ji-Sheng, Liu, Si-Yang, Yang, Ling-Ling, Jiang, Ben-Yuan, Ou, Qiu-Xiang, Qiu, Zhen-Bin, Shao, Yang, Wu, Yi-Long, Zhong, Wen-Zhao
Publicado 2022